September 26-28 AdvaMed 2011

Kenneth Mendez discusses this year’s MedTech Conference for CEOs, business executives, policy makers, financiers, media, and industry stakeholders from around the world.

Read more »

International Stem Cell Corp Develops Similar Embryonic Stem Cells Without Fertilized Embryos

Ken Aldrich, Executive Chairman of International Stem Cell [OTC:ISCO] was interviewed by OneMedRadio where he discussed the company’s regenerative medicine therapies.

Read more »

Vasomedical Announces Agreement to Acquire Two China-Based Companies

Further Implements Global Growth Strategy and Strengthens Manufacturing, Distribution and Technology Base

Read more »

Entellus Completes $35 Million Financing

Minnesota-based Entellus Medical reported that it had completed a $35 million financing round led by Covidien Ventures.

Read more »

Larry Birch Reveals DATATRAK’s Quarterly Results Highest Since 2008

DATATRAK [OTCQX: DATA] continues its recovery with its highest sales since 2008. Larry Birch describes the continued progress for this provider of advanced software systems for the clinical trials industry.

Read more »

Editor’s Note August 16, 2011

OneMedRadio is steadily filling the pipeline with candid interviews with CEOs of some of the most interesting and innovative micro-cap […]

Read more »

InVivo Therapeutics Treats the Spinal Cord Itself, A Novel Technology

Frank Reynolds, President and CEO of InVivo Therapeutics describes the company’s strategy in bringing its unique spinal cord injury (SPI) products to market.

Read more »

August 17, 2011 NYBA Dog Days of Summer Networker

Get out of the heat and into a dry martini at NYBA’s annual celebration of summer!

Read more »

NanoViricides Reports Positive Anti-viral Effect of HIV Drug

NanoViricides’ anti-HIV drug candidate, HIVCide, achieved a positive, long-term effect with fewer and weaker doses than the traditional anti-retroviral combination therapy.

Read more »

Editor’s Note August 8, 2011

We recently introduced OneMedRadio a product designed to bring our readers interviews with the CEOs and investors building some of […]

Read more »